HIGHLIGHTS
- who: Ignacio Brau00f1a and collaborators from the Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain ISPA Translational Immunology Division and Oviedo University School of Medicine, Oviedo, Spain have published the Article: Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center Experience, in the Journal: (JOURNAL)
- what: The authors aimed to analyze the retention rate and safety of IXE in patients with PsA in routine clinical practice. Adverse events (AEs) and drug retention rate were the main study focus. Patients were informed about the objectives of the study but . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.